Cargando…

Prenatal maternal plasma DNA screening for cystic fibrosis: A computer modelling study of screening performance

Background: Prenatal cystic fibrosis (CF) screening is currently based on determining the carrier status of both parents. We propose a new method based only on the analysis of DNA in maternal plasma. Methods: The method relies on the quantitative amplification of the CF gene to determine the percent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Old, Robert W., Bestwick, Jonathan P., Wald, Nicholas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680537/ https://www.ncbi.nlm.nih.gov/pubmed/29167740 http://dx.doi.org/10.12688/f1000research.12849.1

Ejemplares similares

Incorporating DNA Sequencing into Current Prenatal Screening Practice for Down's Syndrome
por: Wald, Nicholas J., et al.
Publicado: (2013)

Cost and efficacy comparison of prenatal recall and reflex DNA screening for trisomy 21, 18 and 13
por: Bestwick, Jonathan Paul, et al.
Publicado: (2019)

Multi-marker risk-based screening for prostate cancer
por: Wald, Nicholas J, et al.
Publicado: (2022)

Improvements in antenatal screening for Down's syndrome
por: Wald, N J, et al.
Publicado: (2013)

Cell-free DNA screening for sex chromosome aneuploidies by non-invasive prenatal testing in maternal plasma
por: Wang, Yipeng, et al.
Publicado: (2020)

Prenatal Screening Using Maternal Markers
por: Cuckle, Howard
Publicado: (2014)

Genetic deconvolution of fetal and maternal cell-free DNA in maternal plasma enables next-generation non-invasive prenatal screening
por: Xu, Chenming, et al.
Publicado: (2022)

Distribution of nuchal translucency in antenatal screening for Down's syndrome
por: Bestwick, J P, et al.
Publicado: (2010)

Antenatal Screening for Down Syndrome Using Serum Placental Growth Factor with the Combined, Quadruple, Serum Integrated and Integrated Tests
por: Wald, Nicholas J., et al.
Publicado: (2012)

Newborn Screening for Cystic Fibrosis in Delaware
por: Shenoy, Ambika, et al.
Publicado: (2018)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

Performance of a Three-Tier (IRT-DNA-IRT) Cystic Fibrosis Screening Algorithm in British Columbia
por: Sinclair, Graham, et al.
Publicado: (2020)

Evaluation of a proposed mixture model to specify the distributions of nuchal translucency measurements in antenatal screening for Down's syndrome
por: Bestwick, J P, et al.
Publicado: (2010)

Cystic fibrosis diagnosed by state newborn screening: Or is it?
por: Fox, Maura, et al.
Publicado: (2020)

Cystic fibrosis: to screen or not to screen? Involving a Citizens' jury in decisions on screening carrier
por: Mosconi, Paola, et al.
Publicado: (2014)

Combining genetic and non-genetic risk factors to predict disease, and reporting the screening performance of risk models
por: Old, Robert
Publicado: (2023)

Overall evaluation of the clinical value of prenatal screening for fetal-free DNA in maternal blood
por: Yu, Bin, et al.
Publicado: (2017)

A Cross-Sectional Study of the Marital Attitudes of Pregnant Women at Risk for Cystic Fibrosis and Psychological Impact of Prenatal Screening
por: Popa, Zoran Laurentiu, et al.
Publicado: (2022)

Noninvasive prenatal screening for cystic fibrosis using circulating trophoblasts: Detection of the 50 most common disease‐causing variants
por: Jeppesen, Line Dahl, et al.
Publicado: (2022)

Communicating cystic fibrosis newborn screening results to parents
por: Seddon, L., et al.
Publicado: (2020)

The Changing Face of Cystic Fibrosis and Its Implications for Screening
por: Naehrlich, Lutz
Publicado: (2020)

Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis
por: Munck, Anne
Publicado: (2020)

History of Newborn Screening for Cystic Fibrosis—The Early Years
por: Travert, Georges, et al.
Publicado: (2020)

Screening strategy for gastrointestinal and hepatopancreatobiliary cancers in cystic fibrosis
por: Hoskins, Brett, et al.
Publicado: (2021)

Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis
por: Khare, Swapnil, et al.
Publicado: (2021)

Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening
por: DeCelie-Germana, Joan Kathleen, et al.
Publicado: (2023)

Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening
por: Hou, Yaping, et al.
Publicado: (2019)

Current Perspectives of Prenatal Cell-free DNA Screening in Clinical Management of First-Trimester Septated Cystic Hygroma
por: Sherer, David M, et al.
Publicado: (2022)

High-resolution computed tomography findings in young infants with cystic fibrosis detected by newborn screening
por: Cohen, Renata Wrobel Folescu, et al.
Publicado: (2019)

Comparison between Gibson–Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive Diagnosis
por: Dolce, Daniela, et al.
Publicado: (2023)

Five-year performance analysis of a cystic fibrosis newborn screening program in northeastern Brazil
por: Godoy, Carolina, et al.
Publicado: (2022)

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
por: Quittner, Alexandra L, et al.
Publicado: (2016)

Why Do We Screen Newborn Infants for Cystic Fibrosis?
por: Barben, Jürg, et al.
Publicado: (2020)

Neonatal Screening for Cystic Fibrosis in Hungary—First-Year Experiences
por: Xue, Andrea, et al.
Publicado: (2023)

A screening tool to identify risk for bronchiectasis progression in children with cystic fibrosis
por: Caudri, Daan, et al.
Publicado: (2021)

Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening
por: Choe, Seung-Ah, et al.
Publicado: (2021)

Randomized Crossover Trial of Phosphate-binding Medication on Serum Phosphate Levels in Patients With Aortic Stenosis
por: Wald, David S., et al.
Publicado: (2019)

Diabetes in Cystic Fibrosis: Multicenter Screening Results Based on Current Guidelines
por: Scheuing, Nicole, et al.
Publicado: (2013)

The Role of Extended CFTR Gene Sequencing in Newborn Screening for Cystic Fibrosis
por: Bergougnoux, Anne, et al.
Publicado: (2020)

Pancreatitis-Associated Protein in Neonatal Screening for Cystic Fibrosis: Strengths and Weaknesses
por: Sommerburg, Olaf, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2vrn6op10jt27i5tkt5ccqfua9